Medtronic plc (MDT) : On Friday, The money flowed into the Medtronic plc (MDT) stock with an uptick to downtick ratio was recorded at 1.2. Transactions worth $160.73 million were done on upticks, confirming the buying interest in the stock. The outflow of money on downticks stood at $133.74 million. The total money flow into the stock was $26.99 million. The block trades reveal a bullish bias with an up-down ratio of 1.6. The investors are using every small weakness in the stock to accumulate it, as can be seen in the $70.15 million of block transactions on upticks. The value of block trades on downticks was $43.82 million, indicating lower selling interest. The total money flow in block trades was $26.33 million. In terms of price action, Medtronic plc (MDT) traded down $0.84 during the session at $87.1. Compared to the previous days closing, the stock was down only by -0.96%. For the week, the stock is -1.43%, over previous weeks closing.
Medtronic plc (MDT) : Currently there are 14 street experts covering Medtronic plc (MDT) stock. The most bullish and bearish price target for the stock is $104 and $56 respectively for the short term. The average price target of all the analysts comes to $89.54. The estimated standard deviation from the target is $11.5.
Medtronic plc (NYSE:MDT): On Fridays trading session , Opening price of the stock was $87.83 with an intraday high of $87.83. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $86.25. However, the stock managed to close at $87.1, a loss of 0.96% for the day. On the previous day, the stock had closed at $87.94. The total traded volume of the day was 8,867,052 shares.
In a related news, Martha Geoffrey, officer (EVP & GroupPres Restora Therap) of Medtronic Plc, unloaded 3,766 shares at an average price of $88.26 on July 15, 2016. The total amount of the transaction was worth $332,387, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.